FDAnews Drug Daily Bulletin

Jazz Pharma Agrees to Sell Women’s Health Business

Sept. 10, 2012
A A
The Irish drugmaker Jazz Pharmaceuticals is selling its women’s health business to specialty pharmaceutical company Meda for $95 million in cash so that it can concentrate on its core products.
Businessweek